Biotech

Category / Pharmaceuticals & Biotech / Biotech

The PROOF Centre of Excellence Partners With HTG Molecular Diagnostics to Begin Clinical Validation of Heart Transplant Rejection Blood Test

TUCSON, AZ: ...

Phase 3 Data on HEPLISAV(TM) in Adults Aged 40-70 and Patients With Chronic Kidney Disease Published in VACCINE

BERKELEY, CA: ...

BioMmune Technologies Inc. Announces the Appointment of Dr. Karoly Nikolich to its Board Of Directors

VANCOUVER, BRITISH COLUMBIA: ...

Cellceutix Plans Phase 2b Trial of New Antibiotic, Reports Fifth Cohort Complete in Novel Cancer Drug Clinical Trial

BEVERLY, MA: ...

Coldstream Laboratories Awarded 5-Year Contract With the National Cancer Institute

LEXINGTON, KY: ...

Groupe Athena, Inc. Announces Revenue Update, Projects $65 Million in Revenues

MUMBAI, INDIA: ...

Preventing the Spread of Antibiotic-Resistant "Nightmare Bacteria" and Superbugs

BARNSTABLE, MA: ...

Itonis Pharmaceuticals and Dr. Charles Hensley Placed First Purchase Order to Produce Emesyl Nausea Remedy

LAGUNA HILLS, CA: ...

Miraculins Announces that Previously Unpublished Study Data Could Accelerate Skin Cholesterol's Use as a New Tool in U.S. Life Insurance Risk Assessment

WINNIPEG, MANITOBA: ...

Achaogen Announces Agreement With FDA on a Special Protocol Assessment for a Phase 3 Clinical Trial of Plazomicin to Treat Infections Caused by Carbapenem-Resistant Enterobacteriaceae (CRE)

SOUTH SAN FRANCISCO, CA: ...

Miraculins Announces First Closing of Private Placement Offering

WINNIPEG, MANITOBA: ...

Algae Biomass Organization Encourages Carbon Capture and Reuse (CCR) in Addition to Carbon Capture and Sequestration (CCS) as Approved Strategy for Compliance With New Emissions Rules for Power Plants

WASHINGTON, DC: ...

Med BioGene Announces Grant of Stock Options

VANCOUVER, BRITISH COLUMBIA: ...

Ceapro Announces Management Change

EDMONTON, ALBERTA: ...

Horizon Pharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference

DEERFIELD, IL: ...

Vital Therapies, Inc. Expands Board of Directors

SAN DIEGO, CA: ...

Food Innovation Offers Major Benefits to Health and Agriculture

CALGARY, ALBERTA: Conference speakers share discoveries that change the way we think about food ...

Jenex Files Financial Statements

TORONTO, ONTARIO: ...

Heat Biologics, Inc. to Present at Aegis Capital Corp. 2013 Healthcare Conference

CHAPEL HILL, NC: ...

Provectus Pharmaceuticals CFO Peter Culpepper Interviewed by The Life Sciences Report

SAN FRANCISCO, CA: ...

Page 116 von 247: 1 « .. 115 116 117 118 119 120 121 122 123 124 .. » 247

All members:	10 565
Register today:	0
Register yesterday:	0
Members online:	1
Guests online:	86

Biotech

Category / Pharmaceuticals & Biotech / Biotech

The PROOF Centre of Excellence Partners With HTG Molecular Diagnostics to Begin Clinical Validation of Heart Transplant Rejection Blood Test

Phase 3 Data on HEPLISAV(TM) in Adults Aged 40-70 and Patients With Chronic Kidney Disease Published in VACCINE

BioMmune Technologies Inc. Announces the Appointment of Dr. Karoly Nikolich to its Board Of Directors

Cellceutix Plans Phase 2b Trial of New Antibiotic, Reports Fifth Cohort Complete in Novel Cancer Drug Clinical Trial

Coldstream Laboratories Awarded 5-Year Contract With the National Cancer Institute

Groupe Athena, Inc. Announces Revenue Update, Projects $65 Million in Revenues

Preventing the Spread of Antibiotic-Resistant "Nightmare Bacteria" and Superbugs

Itonis Pharmaceuticals and Dr. Charles Hensley Placed First Purchase Order to Produce Emesyl Nausea Remedy

Miraculins Announces that Previously Unpublished Study Data Could Accelerate Skin Cholesterol's Use as a New Tool in U.S. Life Insurance Risk Assessment

Achaogen Announces Agreement With FDA on a Special Protocol Assessment for a Phase 3 Clinical Trial of Plazomicin to Treat Infections Caused by Carbapenem-Resistant Enterobacteriaceae (CRE)

Miraculins Announces First Closing of Private Placement Offering

Algae Biomass Organization Encourages Carbon Capture and Reuse (CCR) in Addition to Carbon Capture and Sequestration (CCS) as Approved Strategy for Compliance With New Emissions Rules for Power Plants

Med BioGene Announces Grant of Stock Options

Ceapro Announces Management Change

Horizon Pharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference

Vital Therapies, Inc. Expands Board of Directors

Food Innovation Offers Major Benefits to Health and Agriculture

Jenex Files Financial Statements

Heat Biologics, Inc. to Present at Aegis Capital Corp. 2013 Healthcare Conference

Provectus Pharmaceuticals CFO Peter Culpepper Interviewed by The Life Sciences Report

Service Menu

New here

Who is online